Mylan shareholders re-elect board, reject executive compensation proposals

Shareholders of the embattled drugmaker Mylan voted to re-elect its board members at a meeting Thursday morning, despite pressure to oust select executives amid widespread backlash for the skyrocketing price of EpiPens.  READ MORE